Treatment of severe steroid refractory ulcerative colitis (Q37276958)

19 August 2017

1 reference

title

Treatment of severe steroid refractory ulcerative colitis (English)

1 reference

19 August 2017

1

Gert Van Assche

1 reference

19 August 2017

3

Paul Rutgeerts

1 reference

19 August 2017

Séverine Vermeire

2

1 reference

PMCID

2746336

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

World Journal of Gastroenterology

19 August 2017

1 reference

19 August 2017

14

1 reference

19 August 2017

36

1 reference

19 August 2017

5508-5511

1 reference

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Predicting outcome in severe ulcerative colitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Further experience in the treatment of severe attacks of ulcerative colitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Intravenous cyclosporin in ulcerative colitis: a five-year experience

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Infliximab for hospitalized patients with severe ulcerative colitis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Low-dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Ciclosporin use in acute ulcerative colitis: a long-term experience

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Cortisone in ulcerative colitis; final report on a therapeutic trial.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746336

Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18810767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Infliximab for patients with refractory ulcerative colitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18810767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18810767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.14.5508

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

PMCID

2746336